FindTrial
Sign In

Exploration of the correlation between inflammatory status and tumor prognosis in patients with pancreatic ductal adenocarcinoma

Exploration of the correlation between inflammatory status and tumor prognosis in patients with pancreatic ductal adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077325
Enrollment
Unknown
Registered
2023-11-06
Start date
2023-11-06
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Trail group:NA

Sponsors

Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1: Inpatient of Pancreatic Surgery at Ruijin Hospital from 2012 to 2022 2: Pathological diagnosis of pancreatic ductal adenocarcinoma 3: Surgery (radical or palliative) performed at the pancreatic surgery department of Ruijin Hospital for treatment

Exclusion criteria

Exclusion criteria: 1: Histopathological diagnosis without pancreatic ductal adenocarcinoma component 2: Failed to undergo exploration, puncture, or other surgical treatment in our hospital

Design outcomes

Primary

MeasureTime frame
Albumin;count of white blood cell;count of monocyte;ratio of monocyte;count of lymphocyte;ratio of lymphocyte;lactic dehydrogenase;count of basophil;ratio of basophil;count of eosinophil;ratio of eosinophil;count of platelet;count of neutrophil;ratio of neutrophil;C response protein;ratio of CD3 in lymphocyte;ratio of CD3+CD4+ lymphocyte in lymphocyte;ratio of CD3+CD8+ lymphocyte in lymphocyte;absolute count of CD3;absolute count of CD4;absolute count of CD8;time of death;time of progression;—

Countries

China

Contacts

Public ContactDeng Xiaxing

Ruijin Hospital

dxx10716@rjh.com.cn+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026